Trials / Completed
CompletedNCT00729599
Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.
Single Site Study, Phase III, for Safety Dermatological Evaluation: Basic Acceptability With Odontological Follow up - Cepacol Teen.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 10 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
To prove the safety, in normal conditions, of the Cepacol Teen, a formulation to odontological usage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cetylpyridinium chloride | Cetylpyridinium chloride during 21 consecutive days. |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2008-08-01
- First posted
- 2008-08-07
- Last updated
- 2009-03-04
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00729599. Inclusion in this directory is not an endorsement.